Pharming Group NV has reached a deal with former shareholders of its wholly-owned subsidiary, DNage BV, under which the shareholders will forego €10 million of earn-out payments due to them in return for 49% of DNage and 5 million Pharming shares. ---Subscribe to MedNous to access this article--- Company News
